Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 June 2023 | Story Boitumelo Mokheseng | Photo Supplied
Boitumelo Mokheseng
Boitumelo Mokheseng is a Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Boitumelo Mokheseng, Presidential Youth Employment Initiative (PYEI) Intern in the Qwaqwa Campus Health and Wellness Centre, shares her UFS journey:

Q: Year of graduation from the UFS:

A: 2021.

Q: Qualification obtained from the UFS:

A: Bachelor of Administration.

Q: Date of joining the UFS as a staff member:

A: March 2023.

Q: Initial job title and current job title:

A: PYEI intern in the Qwaqwa Campus Health and Wellness Centre.

Q: How did the UFS prepare you for the professional world?

A: The University of the Free State (UFS) propelled me towards the career path I had always aspired to. The comprehensive education I received not only equipped me with the necessary skills for the workplace, but also fostered a problem-solving mindset that was ingrained in us from our undergraduate years.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: The transition from being a UFS student to a staff member has been wonderful, even though challenging, because now I get to feel the pressure that the clinic staff felt while I was a student. For instance, when visiting the clinic before, I didn’t understand why there are long queues, why we are not assisted in time; since I’m the one assisting the students with the booking systems and making sure they get to the consulting rooms, I now understand how things work.

Q: Any additional comments about your experience?

A: Working here at the UFS has been a dream come true. I am fascinated daily by meeting up with inspiring people who motivate me to do better in life, and I keep learning new things. The experience so far is good; I have acquired new skills, moved from office work and got involved in campaigns such as First Things First where I can engage more with students and meet the different stakeholders from the health department. I’m thankful for the great opportunity the university has given me to be part of it as a staff member – no longer a student.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept